Cargando…
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients
COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing br...
Autores principales: | Ghanbari, Reza, Teimoori, Ali, Sadeghi, Anahita, Mohamadkhani, Ashraf, Rezasoltani, Sama, Asadi, Ebrahim, Jouyban, Abolghasem, Sumner, Susan CJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789744/ https://www.ncbi.nlm.nih.gov/pubmed/33404263 http://dx.doi.org/10.2217/fmb-2020-0120 |
Ejemplares similares
-
Exhaled breath condensate as a potential specimen for diagnosing COVID-19
por: Khoubnasabjafari, Maryam, et al.
Publicado: (2020) -
Surface tension in human pathophysiology and its application as a medical diagnostic tool
por: Fathi-Azarbayjani, Anahita, et al.
Publicado: (2015) -
Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations
por: Duwe, Susanne C., et al.
Publicado: (2021) -
Gut microbiota, epigenetic modification and colorectal cancer
por: Rezasoltani, Sama, et al.
Publicado: (2017) -
The association between gut microbiota, cholesterol gallstones, and colorectal cancer
por: Rezasoltani, Sama, et al.
Publicado: (2019)